Arthroplasty
Dexamethasone plus ramosetron reduces postoperative pain and vomiting following TKA
This report has been verified
by one or more authors of the
original publication.
Clin Orthop Relat Res. 2013 Sep;471(9):3010-20
269 patients, aged 18 and older, scheduled to undergo total knee arthroplasty for primary knee osteoarthritis were randomly assigned into one of two groups to investigate the effect of dexamethasone and ramosetron on postoperative outcomes. Patients intravenously received either both drugs or ramosetron alone. Results demonstrated that patients who received the combination of dexamethasone and ramosetron experienced a greater reduction in postoperative vomiting and pain, and had similar infectious risks as those who received ramosetron alone.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
